Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Clinical study of single-center PDT-ALL-2016 regimen in the treatment of KMT2A-rearranged acute lymphoblastic leukemia

Jiaxin Zheng, Bailin He, Zhixiang Wang, Xuan Zhou, Wenhao Zhong, Qifa Liu, Hongsheng Zhou

Blood (2025) 146 (Supplement 1): 6866.

https://doi.org/10.1182/blood-2025-6866

Published: 2025

Journal Articles

Novel risk stratification of ph-like ALL cohort receiving CD19-directed CAR-T therapy

Cai Zihong, Bailin He, Baiwei Luo, Zhixiang Wang, Wenhao Zhong, Xuan Zhou, Qifa Liu, Peng Li, Yong-xian Hu, Jing PAN, Liang Huang, Hongsheng Zhou

Blood (2025) 146 (Supplement 1): 5108.

https://doi.org/10.1182/blood-2025-5108

Published: 2025

Journal Articles

Neutrophil count is an independent prognostic indicator in early T-cell precursor lymphoblastic leukemia

Jieping Lin, Xiaoyuan Gong, Nanfang Zhuo, Chengming He, Yiming Cai, Zhixiang Wang, Xuan Zhou, Bailin He, Wenhao Zhong, Qifa Liu, Suning Chen, Yang Xu, Huafeng Wang, Ying Wang, Hongsheng Zhou

Blood (2025) 146 (Supplement 1): 6892.

https://doi.org/10.1182/blood-2025-6892

Published: 2025

Journal Articles

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Yifei Huang, Ren Lin, Shanyu Zhang, Zhiping Fan, Fen Huang, Li Xuan, Na Xu, Hui Liu, Zhixiang Wang, Min Dai, Hua Jin, Jing Sun, Qifa Liu

Blood (2024) 144 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2024-202355

Published: 2024

Journal Articles

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 7385.

https://doi.org/10.1182/blood-2024-203334

Published: 2024

Journal Articles

BEAT Chemofree Regimen for Relapsed/Refractory and De Novo T-ALL

Jieping Lin, Xuan Zhou, Zhixiang Wang, Dainan Lin, Yu Zhan, Zan Li, Jiwei Huang, Yonghua Li, Xudong Ma, Qifa Liu, Li Xuan, Yang Xu, Hongsheng Zhou

Blood (2024) 144 (Supplement 1): 5901.

https://doi.org/10.1182/blood-2024-203250

Published: 2024

Journal Articles

Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial

Jieping Lin, Chenhao Ding, Zicong Huang, Cai Zihong, Jia Li, Zhixiang Wang, Xiaofang Li, Xuan Zhou, Bailin He, Wenhao Zhong, Li Xuan, Qifa Liu, Yang Xu, Hongsheng Zhou

Blood (2024) 144 (Supplement 1): 839.

https://doi.org/10.1182/blood-2024-200513

Published: 2024

Journal Articles

The Pediatric-Inspired Regimen Improved Quality and Quantity of Life for Patients with Acute Lymphoblastic Leukemia，Beyond Age, Risk Stratification, and Hematopoietic Stem Cell Transplantation

Junjie Chen, Zhixiang Wang, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 1466.

https://doi.org/10.1182/blood-2023-188479

Published: 2023

Journal Articles

Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Zhonghui Jiang, Zhiping Fan, Hui Xu, Na Xu, Tian Zhang, Huiwen Xue, Ren Lin, Zhixiang Wang, Ling Jiang, Jing Sun, Li Xuan

Blood (2023) 142 (Supplement 1): 4871.

https://doi.org/10.1182/blood-2023-178337

Published: 2023

Journal Articles

Allo-HSCT Improved Outcome of High Risk ALL in Pediatric-Inspired PDT-ALL-2016 Cohort

Junjie Chen, Zhixiang Wang, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 2229.

https://doi.org/10.1182/blood-2023-185940

Published: 2023

Journal Articles

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Fen Huang, Jing Du, Pinjing Lv, Kaibo Yang, Zhiping Fan, Li Xuan, Jing Sun, Na Xu, Hui Liu, Pengcheng Shi, Xiaofang LI, Jun Xu, Zhixiang Wang, Pu Wang, Xiang Yao, Ye Chen, Qifa Liu

Blood (2023) 142 (Supplement 1): 3569.

https://doi.org/10.1182/blood-2023-179098

Published: 2023

Journal Articles

Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement

Bailin He, Hongsheng Zhou, Ren Lin, Zhixiang Wang, Na Xu, Qiang Wang, Jing Sun, Xiaoli Liu, Peng Li, Qifa Liu

Blood (2023) 142 (Supplement 1): 3484.

https://doi.org/10.1182/blood-2023-184492

Published: 2023

Journal Articles

IKZF1deletions Coupled with CD20 Expression Represents a Novel High-Risk Subtype in Adult B-Cell Progenitor Acute Lymphoblastic Leukemia

Bingqing Tang, Zhixiang Wang, Dainan Lin, Xianjun He, Zihong Cai, Kangyu Huang, Xuan Zhou, Ren Lin, Liu Xiaoli, Na Xu, Fen Huang, Jing Sun, Qifa Liu, Hongsheng Zhou

Blood (2021) 138 (Supplement 1): 4474.

https://doi.org/10.1182/blood-2021-154271

Published: 2021

Journal Articles

Prophylactic Donor Lymphocyte Infusion Based on Two Different Time for Preventing Relapse in Advanced Acute Leukemia Undergoing Allo-HSCT: Comparison of Two Independent Prospective Cohorts

Qiongqiong Su, Zhiping Fan, MD, Fen Huang, Na Xu, Danian Nie, MD, Dongjun Lin, MD, Ziwen Guo, MD, Shi Pengcheng, Zhixiang Wang, Ling Jiang, Jing Sun, MD, Zujun Jiang, Qifa Liu, MD, Li Xuan, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-137404

Published: 2020

Journal Articles

Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed /Refractory Acute Myeloid Leukemia

Guopan Yu, Na Xu, Fen Huang, Zhiping Fan, MD, Hui Liu, Pengcheng Shi, Hongsheng Zhou, MD PhD, Zhixiang Wang, Yu Zhang, Qifa Liu, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-138676

Published: 2020

Journal Articles

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

Guo-Pan Yu, MD, Zhao Yin, Zhiping Fan, Fen Huang, Na Xu, Ling Jiang, Zhixiang Wang, PhD, Li Xuan, MD, Qifa Liu, MD, Ru Feng, MD, Jing Sun

Blood (2019) 134 (Supplement_1): 5659.

https://doi.org/10.1182/blood-2019-126705

Published: 2019

Journal Articles

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

Zhiping Fan, MD, Lan Deng, MD PhD, Xudong Li, Qing Zhang, MD, Li Xuan, Fen Huang, Ren Lin, Hua Jin, Na Xu, PhD, Pengcheng Shi, Zhixiang Wang, PhD, Jieyu Ye, Ling Jiang, Jing Sun, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 5724.

https://doi.org/10.1182/blood-2018-99-117430

Published: 2018

Journal Articles

Berberine Acts As a Putative Epigenetic Modulator By Affecting Histone Code in Acute Myelocytic Leukemia Cells

Zhixiang Wang, PhD, Qifa Liu, Xuejie Jiang, MD, Yu Zhang, PhD, Ling Jiang, PhD MD, Fanyi Meng

Blood (2017) 130 (Supplement 1): 4989.

https://doi.org/10.1182/blood.V130.Suppl_1.4989.4989

Published: 2017

Journal Articles

MiR-144 Targets APP to Regulate AML1/ETO+ Leukemia Cell Migration Via p-ERK/c-Myc/MMP-2 Pathway

Fanyi Meng, Ling Jiang, PhD MD, Wei Meng, PhD, Guo-Pan Yu, MD, Yin Changxin, Zhixiang Wang, PhD, Xuejie Jiang, MD, Qifa Liu

Blood (2017) 130 (Supplement 1): 5093.

https://doi.org/10.1182/blood.V130.Suppl_1.5093.5093

Published: 2017

Journal Articles

APP Gene Involves in the Regulation of Cell Apoptosis in AML1-ETO-Positive Leukemia Via SCF/c-Kit Signaling Pathway

Guopan Yu, Ling Jiang, Changxin Yin, Zhixiang Wang, Hongsheng Zhou, Xuejie Jiang, Qifa Liu, MD, Fanyi Meng

Blood (2015) 126 (23): 3647.

https://doi.org/10.1182/blood.V126.23.3647.3647

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Clinical study of single-center PDT-ALL-2016 regimen in the treatment of KMT2A-rearranged acute lymphoblastic leukemia

Novel risk stratification of ph-like ALL cohort receiving CD19-directed CAR-T therapy

Neutrophil count is an independent prognostic indicator in early T-cell precursor lymphoblastic leukemia

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

BEAT Chemofree Regimen for Relapsed/Refractory and De Novo T-ALL

Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial

The Pediatric-Inspired Regimen Improved Quality and Quantity of Life for Patients with Acute Lymphoblastic Leukemia，Beyond Age, Risk Stratification, and Hematopoietic Stem Cell Transplantation

Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Allo-HSCT Improved Outcome of High Risk ALL in Pediatric-Inspired PDT-ALL-2016 Cohort

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement

IKZF1deletions Coupled with CD20 Expression Represents a Novel High-Risk Subtype in Adult B-Cell Progenitor Acute Lymphoblastic Leukemia

Prophylactic Donor Lymphocyte Infusion Based on Two Different Time for Preventing Relapse in Advanced Acute Leukemia Undergoing Allo-HSCT: Comparison of Two Independent Prospective Cohorts

Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed /Refractory Acute Myeloid Leukemia

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

Berberine Acts As a Putative Epigenetic Modulator By Affecting Histone Code in Acute Myelocytic Leukemia Cells

MiR-144 Targets APP to Regulate AML1/ETO+ Leukemia Cell Migration Via p-ERK/c-Myc/MMP-2 Pathway

APP Gene Involves in the Regulation of Cell Apoptosis in AML1-ETO-Positive Leukemia Via SCF/c-Kit Signaling Pathway

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only